Schneider, Lon S.

Sertraline for the treatment of depression in Alzheimer disease

Rosenberg, P. B., Martin, B. K., Frangakis, C., Mintzer, J. E., Weintraub, D., Porsteinsson, A. P., Schneider, L. S., Rabins, P. V., Munro, C. A., Meinert, C. L., et al. (2010) · The American Journal of Geriatric Psychiatry

Dementia and Cognitive Impairment ResearchTreatment of Major Depression

Cited by 250

Efficacy of Second Generation Antidepressants in Late-Life Depression: A Meta-Analysis of the Evidence

Nelson, J. C., Delucchi, K., & Schneider, L. S. (2008) · The American Journal of Geriatric Psychiatry

Treatment of Major DepressionMental Health Treatment and Access

Cited by 230

Effects of Multiple Genetic Loci on Age at Onset in Late-Onset Alzheimer Disease: A Genome-Wide Association Study

Naj, A. C., Jun, G., Reitz, C., Kunkle, B. W., Perry, W., Park, Y. S., Beecham, G. W., Rajbhandary, R. A., Hamilton-Nelson, K. L., Wang, L.-S., et al. (2014) · JAMA Neurology

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 185

Cholinesterase Inhibition for Alzheimer Disease: A Meta-analysis of the Tacrine Trials

Qizilbash, N., Whitehead, A., Higgins, J., Wilcock, G., Schneider, L., Farlow, M., & for the Dementia Trialists' Collaboration (1998) · JAMA

Cholinesterase and Neurodegenerative DiseasesDementia and Cognitive Impairment Research

Cited by 161

Vascular burden and Alzheimer disease pathologic progression

Lo, R. Y., Jagust, W. J., Weiner, M., Aisen, P., Weiner, M., Aisen, P., Petersen, R., Jack, C. R., Jagust, W., Trojanowki, J. Q., et al. (2012) · Neurology

Dementia and Cognitive Impairment ResearchNeurological Disease Mechanisms and Treatments

Cited by 156

Designing drug trials for Alzheimer's disease: what we have learned from the release of the phase III antibody trials: a report from the EU/US/CTAD Task Force

Vellas, B., Carrillo, M. C., Sampaio, C., Brashear, H. R., Siemers, E., Hampel, H., Schneider, L. S., Weiner, M., Doody, R., Khachaturian, Z., et al. (2013) · Alzheimer's & Dementia

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 147

Diversity in Alzheimer's disease drug trials: the importance of eligibility criteria

Franzen, S., Smith, J. E., van den Berg, E., Rivera Mindt, M., van Bruchem‐Visser, R. L., Abner, E. L., Schneider, L. S., Prins, N. D., Babulal, G. M., & Papma, J. M. (2022) · Alzheimer's & Dementia

Ethics in Clinical ResearchDementia and Cognitive Impairment Research

Cited by 146

Nutrition state of science and dementia prevention: recommendations of the Nutrition for Dementia Prevention Working Group

Yassine, H. N., Samieri, C., Livingston, G., Glass, K., Wagner, M., Tangney, C., Plassman, B. L., Ikram, M. A., Voigt, R. M., Gu, Y., et al. (2022) · The Lancet Healthy Longevity

Dementia and Cognitive Impairment ResearchNutritional Studies and Diet

Cited by 116

The need to show minimum clinically important differences in Alzheimer's disease trials

Liu, K. Y., Schneider, L. S., & Howard, R. (2021) · The Lancet Psychiatry

Statistical Methods in Clinical TrialsAlzheimer's disease research and treatments

Cited by 113

Risperidone in the treatment of psychosis of alzheimer disease: Results from a prospective clinical trial

Mintzer, J., Greenspan, A., Caers, I., Van Hove, I., Kushner, S., Weiner, M., Gharabawi, G., & Schneider, L. S. (2006) · The American Journal of Geriatric Psychiatry

Dementia and Cognitive Impairment ResearchSchizophrenia research and treatment

Cited by 94

Changes in QTc Interval in the Citalopram for Agitation in Alzheimer's Disease (CitAD) Randomized Trial

Drye, L. T., Spragg, D., Devanand, D. P., Frangakis, C., Marano, C., Meinert, C. L., Mintzer, J. E., Munro, C. A., Pelton, G., Pollock, B. G., et al. (2014) · PLoS ONE

Cardiac electrophysiology and arrhythmiasPharmacovigilance and Adverse Drug Reactions

Cited by 59

Longitudinal measurement and hierarchical classification framework for the prediction of Alzheimer’s disease

Huang, M., Yang, W., Feng, Q., Chen, W., Initiative, T. A. D. N., Weiner, M. W., Aisen, P., Petersen, R., Jack, C. R., Jagust, W., et al. (2017) · Scientific Reports

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 55

Citalopram for agitation in Alzheimer's disease: Design and methods

Drye, L. T., Ismail, Z., Porsteinsson, A. P., Rosenberg, P. B., Weintraub, D., Marano, C., Pelton, G., Frangakis, C., Rabins, P. V., Munro, C. A., et al. (2012) · Alzheimer's & Dementia

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 52

Multimodal Hippocampal Subfield Grading For Alzheimer’s Disease Classification

Hett, K., Ta, V.-T., Catheline, G., Tourdias, T., Manjón, J. V., Coupé, P., Initiative, A. D. N., Weiner, M. W., Aisen, P., Petersen, R., et al. (2019) · Scientific Reports

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 49

Cognitive Outcomes After Sertaline Treatment in Patients With Depression of Alzheimer Disease

Munro, C. A., Longmire, C. F., Drye, L. T., Martin, B. K., Frangakis, C. E., Meinert, C. L., Mintzer, J. E., Porsteinsson, A. P., Rabins, P. V., Rosenberg, P. B., et al. (2012) · The American Journal of Geriatric Psychiatry

Dementia and Cognitive Impairment ResearchTreatment of Major Depression

Cited by 49

Genetic studies of plasma analytes identify novel potential biomarkers for several complex traits

Deming, Y., Xia, J., Cai, Y., Lord, J., Del-Aguila, J. L., Fernandez, M. V., Carrell, D., Black, K., Budde, J., Ma, S., et al. (2016) · Scientific Reports

Genetic Associations and EpidemiologyGenetic Mapping and Diversity in Plants and Animals

Cited by 28

Change in agitation in Alzheimer's disease in the placebo arm of a nine-week controlled trial

Rosenberg, P. B., Drye, L. T., Porsteinsson, A. P., Pollock, B. G., Devanand, D. P., Frangakis, C., Ismail, Z., Marano, C., Meinert, C. L., Mintzer, J. E., et al. (2015) · International Psychogeriatrics

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 28

Recruitment methods for united states Alzheimer disease prevention trials

Schneider, L. S. (2012) · The Journal of nutrition, health and aging

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 22

Circular-SWAT for deep learning based diagnostic classification of Alzheimer's disease: application to metabolome data

Jo, T., Kim, J., Bice, P., Huynh, K., Wang, T., Arnold, M., Meikle, P. J., Giles, C., Kaddurah-Daouk, R., Saykin, A. J., et al. (2023) · eBioMedicine

Dementia and Cognitive Impairment ResearchMetabolomics and Mass Spectrometry Studies

Cited by 15

A Polymorphism Cluster at the 2q12 locus May Predict Response to Piromelatine in Patients with Mild Alzheimer's Disease

Schneider, L. S., Laudon, M., Nir, T., Caceres, J., Ianniciello, G., Capulli, M., & Zisapel, N. (2022) · The Journal of Prevention of Alzheimer's Disease

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 13

Consensus meta-analysis of genome-wide association studies for Alzheimer’s disease and related dementias

EADB, Bellenguez, C., Castillo Morales, A., Amin, N., van der Lee, S. J., Muntaner, M., Parveen, K., Küçükali, F., Grenier-Boley, B., Heikkinen, S., et al. (2026) · Nature Genetics

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 7